Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Estriol

Estriol

50-27-1

DISCOVER
ENTEROKINASE BRP (200 MG)

ENTEROKINASE BRP (200 MG)

9014-74-8

DISCOVER
Estrone

Estrone

53-16-7

DISCOVER
Estrone-16,16 D2

Estrone-16,16 D2

56588-58-0

DISCOVER
EPHEDRINE HYDROCHLORIDE CRS -* DRUG PRECURSOR (160 MG)

EPHEDRINE HYDROCHLORIDE CRS -* DRUG PRECURSOR (160 MG)

50-98-6

DISCOVER
EPHEDRINE HYDROCHLORIDE (RACEMIC) CRS - * DRUG PRECURSOR (50

EPHEDRINE HYDROCHLORIDE (RACEMIC) CRS - * DRUG PRECURSOR (50

134-71-4

DISCOVER
4-EPIANHYDROTETRACYCLINE HYDROCHLORIDE CRS (25 MG)

4-EPIANHYDROTETRACYCLINE HYDROCHLORIDE CRS (25 MG)

4465-65-0

DISCOVER
Enrofloxacine

Enrofloxacine

93106-60-6

DISCOVER
EPIRUBICIN HYDROCHLORIDE CRS (100 MG)

EPIRUBICIN HYDROCHLORIDE CRS (100 MG)

56390-09-1

DISCOVER
Eprinomectin

Eprinomectin

123997-26-2

DISCOVER
Econazole nitrate salt

Econazole nitrate salt

24169-02-6

DISCOVER
4-EPITETRACYCLINE HYDROCHLORIDE CRS (40 MG)

4-EPITETRACYCLINE HYDROCHLORIDE CRS (40 MG)

23313-80-6

DISCOVER